Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Newsted

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
Approach to hearing lossDaniel Newsted, Emily Rosen, Bonnie Cooke, et al.
Dementia and Geriatric Cognitive Disorders|May 26, 2023
Hearing Loss and Dementia: A Population-Based Cohort StudyKeshinisuthan Kirubalingam, Paul Nguyen, Daniel Newsted, et al.
Oncotarget|September 24, 2017
A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer modelsBinbing Ling, Kathleen Watt, Sunandan Banerjee, et al.
The Journal of Family Practice|March 8, 2022
How to identify balance disorders and reduce fall riskDaniel Newsted, Dougal Bale, Maxine Armstrong, et al.
Scientific Reports|November 24, 2018
Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and MetastasisSarah Nersesian, Rodette Williams, Daniel Newsted, et al.
British Journal of Cancer|April 15, 2024
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responsesJacob Kment, Daniel Newsted, Stephanie Young, et al.
Cellular Signalling|June 24, 2018
MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinomaKathleen Watt, Daniel Newsted, Elena Voorand, et al.
Nature Communications|April 15, 2018
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritisAlessandro Angelini, Yoshishige Miyabe, Daniel Newsted, et al.
Oncoimmunology|February 5, 2019
Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer modelsDaniel Newsted, Sunandan Banerjee, Kathleen Watt, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
Approach to hearing lossDaniel Newsted, Emily Rosen, Bonnie Cooke, et al.
Dementia and Geriatric Cognitive Disorders|May 26, 2023
Hearing Loss and Dementia: A Population-Based Cohort StudyKeshinisuthan Kirubalingam, Paul Nguyen, Daniel Newsted, et al.
Oncotarget|September 24, 2017
A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer modelsBinbing Ling, Kathleen Watt, Sunandan Banerjee, et al.
The Journal of Family Practice|March 8, 2022
How to identify balance disorders and reduce fall riskDaniel Newsted, Dougal Bale, Maxine Armstrong, et al.
Scientific Reports|November 24, 2018
Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and MetastasisSarah Nersesian, Rodette Williams, Daniel Newsted, et al.
British Journal of Cancer|April 15, 2024
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responsesJacob Kment, Daniel Newsted, Stephanie Young, et al.
Cellular Signalling|June 24, 2018
MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinomaKathleen Watt, Daniel Newsted, Elena Voorand, et al.
Nature Communications|April 15, 2018
Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritisAlessandro Angelini, Yoshishige Miyabe, Daniel Newsted, et al.
Oncoimmunology|February 5, 2019
Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer modelsDaniel Newsted, Sunandan Banerjee, Kathleen Watt, et al.
Pageof 2